Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IAPP | P10997 | 5/20 | 0.67 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.47 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.46 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | DBH | P09172 | 1/20 | 0.45 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | EGFR | P00533 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | FYN | P06241 | 1/20 | 0.44 |
| ▸ | MMP2 | P08253 | 1/20 | 0.44 |
| ▸ | MMP9 | P14780 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | MMP8 | P22894 | 1/20 | 0.44 |
| ▸ | CA6 | P23280 | 1/20 | 0.44 |
| ▸ | CDK2 | P24941 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31013617 | 1.00 | IAPP (0.67) | IAPPAKR1B1GABRA1GABRB2THRB | |
| SCHEMBL30176200 | 0.83 | AKR1B1 (0.68) | IAPPAKR1B1THRBCA2LMNA | |
| SCHEMBL266802 | 0.83 | AKR1B1 (0.68) | IAPPAKR1B1THRBCA2LMNA | |
| SCHEMBL660344 | 0.83 | IAPP (0.46) | IAPP | |
| SCHEMBL28717700 | 0.83 | IAPP (0.56) | IAPPAKR1B1GABRA1GABRB2DBH | |
| SCHEMBL2545614 | 0.82 | IAPP (0.50) | IAPPAKR1B1GABRA1GABRB2THRB | |
| SCHEMBL5991730 | 0.82 | ALDH1A1 (0.50) | IAPPGABRA1GABRB2ALDH1A1EGFR | |
| SCHEMBL29829095 | 0.81 | AKR1B1 (0.72) | IAPPAKR1B1THRBDBHADAMTS4 | |
| SCHEMBL8791 | 0.81 | AKR1B1 (0.72) | IAPPAKR1B1THRBDBHADAMTS4 | |
| SCHEMBL9130849 | 0.81 | IAPP (0.44) | IAPP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117214316-A | Method for controlling mass of detumescence and analgesia composition | 广西壮族自治区花红药业集团股份公司 | 2023-12-12 | — | — | CN | claimed |
| US-20200205541-A1 | METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN AROMATIC COMPOUND | L'OREAL (FR) | 2020-07-02 | — | — | US | claimed |
| US-20130298933-A1 | METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN AROMATIC COMPOUND | L'OREAL (FR) | 2013-11-14 | — | — | US | claimed |
| US-20100300472-A1 | METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN AROMATIC COMPOUND | L'OREAL S.A. (FR) | 2010-12-02 | — | — | US | claimed |
| EP-4740962-A1 | PHARMACEUTICAL COMPOSITION, FORMULATION CONTAINING PHARMACEUTICAL COMPOSITION, KIT CONTAINING PHARMACEUTICAL COMPOSITION, PREPARATION METHOD FOR PHARMACEUTICAL COMPOSITION, AND USE OF PHARMACEUTICAL COMPOSITION | Shanghai WD Pharmaceutical Co., Ltd (CN) | 2026-05-13 | — | — | EP | disclosed |
| US-20250281390-A1 | OSMOTIC PUMP TABLET, PREPARATION METHOD THEREFOR AND USE THEREOF | SHANGHAI WD PHARMACEUTICAL CO., LTD (CN) | 2025-09-11 | — | — | US | disclosed |
| WO-2025007958-A1 | PHARMACEUTICAL COMPOSITION, FORMULATION CONTAINING PHARMACEUTICAL COMPOSITION, KIT CONTAINING PHARMACEUTICAL COMPOSITION, PREPARATION METHOD FOR PHARMACEUTICAL COMPOSITION, AND USE OF PHARMACEUTICAL COMPOSITION | 上海汉都医药科技有限公司 | 2025-01-09 | — | — | WO | disclosed |
| CN-119258225-A | Pharmaceutical composition, preparation containing pharmaceutical composition, kit and preparation method and application of pharmaceutical composition | 上海汉都医药科技有限公司 | 2025-01-07 | — | — | CN | disclosed |
| US-20240269443-A1 | ORAL RETENTION DEVICE AND OSMOTIC PUMP TABLET, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | SHANGHAI WD PHARMACEUTICAL CO LTD (CN) | 2024-08-15 | — | — | US | disclosed |
| CN-118185788-A | Pseudomonas oleovorax and application thereof | 青岛蔚蓝赛德生物科技有限公司 | 2024-06-14 | — | — | CN | disclosed |
| US-11911513-B2 | Controlled-release system of active pharmaceutical ingredient and preparation method therefor | SHANGHAI WD PHARMACEUTICAL CO., LTD (CN) | 2024-02-27 | — | — | US | disclosed |
| CN-117214316-A | Method for controlling mass of detumescence and analgesia composition | 广西壮族自治区花红药业集团股份公司 | 2023-12-12 | — | — | CN | disclosed |
| US-20120192888-A1 | PROCESS FOR STRAIGHTENING KERATIN FIBRES WITH A HEATING MEANS AND DENATURING AGENTS | L 'Oréal S.A., (FR) | 2012-08-02 | — | — | US | disclosed |
| EP-1670450-B8 | PHARMACEUTICAL COMPOSITIONS AND METHOD OF USING LEVODOPA AND CARBIDOPA | CENTOCOR ORTHO BIOTECH INC (US) | 2011-03-23 | — | — | EP | disclosed |
| US-20100300472-A1 | METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN AROMATIC COMPOUND | L'OREAL S.A. (FR) | 2010-12-02 | — | — | US | disclosed |
| US-20100028280-A1 | PROCESS FOR STRAIGHTENING KERATIN FIBRES WITH A HEATING MEANS AND DENATURING AGENTS | L'OREAL S.A. (FR) | 2010-02-04 | — | — | US | disclosed |
| EP-1670450-A4 | PHARMACEUTICAL COMPOSITIONS AND METHOD OF USING LEVODOPA AND CARBIDOPA | TRANSFORM PHARMACEUTICALS INC (US) | 2008-08-27 | — | — | EP | disclosed |
| EP-1670450-A2 | PHARMACEUTICAL COMPOSITIONS AND METHOD OF USING LEVODOPA AND CARBIDOPA | Transform Pharmaceuticals, Inc. (US) | 2006-06-21 | — | — | EP | disclosed |
| WO-2005023185-A2 | PHARMACEUTICAL COMPOSITIONS AND METHOD OF USING LEVODOPA AND CARBIDOPA | TRANSFORM PHARMACEUTICALS, INC. (US) | 2005-03-17 | — | — | WO | disclosed |
| EP-0350069-A2 | Method for oxidizing unsaturated aromatic compounds | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1990-01-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120192888-A1 | PROCESS FOR STRAIGHTENING KERATIN FIBRES WITH A HEATING MEANS AND DENATURING AGENTS | KRT18, KRTCAP2, TUBB4A | IAPP 2481/4885AKR1B1 613/4885GABRA1 4655/4885 |
| US-20200205541-A1 | METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN AROMATIC COMPOUND | KRT18, TUBB4A, TUBB4B | IAPP 4122/4885AKR1B1 180/4885GABRA1 4755/4885 |
| US-20100028280-A1 | PROCESS FOR STRAIGHTENING KERATIN FIBRES WITH A HEATING MEANS AND DENATURING AGENTS | KRT18, KRTCAP2, TUBB4A | IAPP 2481/4885AKR1B1 613/4885GABRA1 4655/4885 |
| US-20100300472-A1 | METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN AROMATIC COMPOUND | KRT18, TUBB4A, TUBB4B | IAPP 4122/4885AKR1B1 180/4885GABRA1 4755/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.